AzTrials
AzTrials

Complication,PostoperativeNCT06338007

Relationship Between Hand Dynamometer Measurements, PFT, and mFI With Postoperative Outcomes

An observational study of Complication,Postoperative and Lung Cancer, run by Atatürk Chest Diseases and Chest Surgery Training and Research Hospital at 1 site in Turkey (Türkiye).

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The study will take place at SBÜ Ankara Atatürk Sanatorium Training and Research Hospital and will include 100 patients over the age of 40 who are scheduled for lung malignancy surgery after 01 April 2024. Informed consent will be obtained from all patients, who will be assigned a number from 1 to 100. Read more about this study

Who is it for?
Ages 40 years and older
Conditions the study is for
Complication,Postoperative, Lung Cancer
What is being tested?
Hand Dynamometer, Pulmonary Function Test and Modified Frailty Index
Type of treatment
Medical device
How many people
100 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 May 2024to 1 Jan 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: During a 3-month period, we calculated that we needed 91 patients to achieve a 95% confidence level with a margin of error of ±5%. This calculation was based on the assumption that 40% of all surgical patients in our clinic had malignant lung resection. We selected a sample size of 100, taking into account possible non-study factors.

Who may be able to join

  • All patients over the age of 40 who will undergo lung resection due to malignancy

Who cannot join

  • Patients undergoing emergency surgery
  • Patients with missing preoperative measurements
  • Patients with missing 90-day follow-up data

Trial locations and contacts

1 site in 1 country.

Gülay ÜLGER, specialist contact

05059532122 ext. +9

gulayulger@gmail.com

Turkey (Türkiye)1 site
  • Ankara Atatürk Sanatorium Training and Research Hospital

    Ankara, Keçiören, 06290

    Gülay ÜLGER, specialist, 05059532122 ext. +9, gulayulger@gmail.com

    Onur KÜÇÜK, specialist

Other trials in Turkey (Türkiye)

About this study

Official title: The Relationship of Preoperative Hand Dynamometer Measurement, Pulmonary Function Tests and Modified Frailty Index With Postoperative Outcomes in Patients Undergoing Lung Resection

The study will take place at SBÜ Ankara Atatürk Sanatorium Training and Research Hospital and will include 100 patients over the age of 40 who are scheduled for lung malignancy surgery after 01 April 2024. Informed consent will be obtained from all patients, who will be assigned a number from 1 to 100.

For patients over 40 years of age who are scheduled to undergo lung malignancy resection surgery, demographic data including age, gender, height, weight, body mass index (BMI), diagnosis, comorbidities, and ASA (American Society of Anaesthesiologist) score will be recorded. In addition, hand grip strength measurement, pulmonary function test, and modified frailty index (a scoring system that includes 11 parameters) will be recorded prior to surgery. Intraoperative and postoperative complications will be documented. The duration of the patient's stay in the intensive care unit, chest tube removal, length of hospital stay, and postoperative complications will also be recorded. A follow-up call will be made to the patient by the responsible researcher 90 days after the operation to inquire about any complications that may have developed within that time frame.

The study aims to investigate the relationship between preoperative hand grip strength measurement, pulmonary function test analysis (PFT), and modified frailty index with the duration of intensive care unit stay, chest tube withdrawal time, hospital stay, and postoperative complications in patients undergoing lung resection due to malignancy.

Being tested
Hand Dynamometer, Pulmonary Function Test, Modified Frailty Index
Keywords
Lung Cancer, postoperative complication, modified frailty index, pulmonary function test, hand grip strength measurement
Medical subject headings
Postoperative Complications, Lung Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Hand DynamometerDevice

    Hand grip strength will be measured using a hand dynamometer. Research has demonstrated that hand grip strength is correlated with muscle strength in the upper extremities, as well as overall body and pulmonary muscle strength.

  • Pulmonary Function TestDiagnostic test

    Also called Spirometry

    Spirometry is a physiological test that measures the ability to inhale and exhale air relative to time. Spirometry is a diagnostic test of several common respiratory disperses such as asthma and chronic obstructive pulmonary disease (COPD). It is also instrumental in monitoring the progression of various respiratory disorders. The main results of spirometry are forced vital capacity (FVC), forced expiratory volume exhaled in the first second (FEV1), and the FEV1/FVC ratio. Pulmonary Function Test analysis values (FEV1, FVC and FEV1 /FVC) will be used.

  • Modified Frailty IndexOther

    The modified frailty index is a valuable preoperative risk assessment tool that can be used to assess the risk of both morbidity and mortality in patients undergoing surgery. It is calculated based on 11 parameters.

Study groups in NCT06338007
Study groupRoleWhat they receive
Complications (No)Patients who did not experience any postoperative complications within 90 days.
Receives: Device: Hand Dynamometer; Diagnostic Test: Pulmonary Function Test; Other: Modified Frailty Index
Complications (Yes)Patients who experienced any complications within 90 days after surgery.
Receives: Device: Hand Dynamometer; Diagnostic Test: Pulmonary Function Test; Other: Modified Frailty Index

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Complication

    Complication data for patients who underwent lung resection for malignancy during the 90-day follow-up period.

    Measured: 90 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Mar 2024
  2. Study start1 May 2024 (estimated)
  3. Primary completion1 Sep 2024 (estimated)
  4. Study completion1 Jan 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06338007
Sponsor's protocol ID
2012-KAEK-15/2702
Status last verified
Apr 2024
First submitted
24 Mar 2024
Last updated
17 Apr 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Complication,Postoperative and Lung Cancer, run by Atatürk Chest Diseases and Chest Surgery Training and Research Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 17 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Gülay ÜLGER, specialist (05059532122 ext. +9, gulayulger@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Complication (time frame: 90 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Apr 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in